DERMIS

GOAL

Evaluation of the efficacy of low-level laser therapy in the management of acute radiodermatitis in breast cancer patients

STUDY DESIGN

Pilot trial with breast cancer patients undergoing radiotherapy after a breast sparing surgery at the Jessa Hospital  (NCT01932073) from August 2013 until April 2014

Control group (n=41)	Laser group (n=38)
Standard skin care	Standard skin care
Radiotherapy standard regimen	Radiotherapy standard regimen
/	LLLT (2x/week, from dose 40 Gy)

STUDY RESULTS

LLLT diminishes the severity of acute radiodermatitis during radiotherapy with 30% and improves the patient's quality of life

PUBLICATIONS

Censabella S, Claes S, Robijns J, Bulens, Mebis J. Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS® laser therapy
in breast cancer patients. Support Care Cancer. 2016 Sep;24(9):3925-33. 
Impact factor 2016: 2.698

PARTNERS